News | May 27, 2026
Jubilant Ingrevia delivers 14-quarter high revenue in Q4 FY26 as margins strengthen across biz
The company highlighted continued demand strength and pricing resilience despite global disruptions
The company highlighted continued demand strength and pricing resilience despite global disruptions
The company is also highlighting early-stage innovation in antibody-drug conjugates and in vivo CAR-T therapy
Q4 FY26 PAT jumps 44% to Rs. 271 crore, supported by acquisitions, specialty expansion, and diagnostics momentum
More than 450 public and private health technology solutions have integrated with the Ayushman Bharat Digital Mission ecosystem
Eye care major expands network to 288 facilities across 10 countries after adding 57 new centres during FY26
Collaboration with Siddhi Diagnostics combines genomics and advanced imaging capabilities to strengthen precision diagnostics in high-growth suburban markets
Nearly one in five women worldwide are now living with obesity
The company plans to collaborate with European medical centres to expand adoption of its robotic microsurgery platform
The biosimilars business generated Rs. 10,431 crore in FY26 revenue, up 16% year-on-year
Company handles 20,000+ AI-driven calls and chats daily as it scales agentic AI systems across healthcare workflows
Subscribe To Our Newsletter & Stay Updated
